Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shao-Fa is a traditional Chinese patent medicine (TCPM) primarily indicated for the treatment of various forms of alopecia, including alopecia areata and seborrheic alopecia, as well as the premature graying of hair. Formulated typically as capsules or oral liquids, it is based on Traditional Chinese Medicine (TCM) principles designed to nourish the liver and kidney and tonify the blood, which are believed to be the underlying biological systems governing hair health and pigmentation. The product contains a complex mixture of herbal extracts, with key active ingredients including *Rehmannia glutinosa*, *Polygonum multiflorum* (He Shou Wu), and *Angelica sinensis*. These components are thought to work synergistically to stimulate hair follicles, improve local blood circulation in the scalp, and provide essential nutrients for hair growth and melanin production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shao-Fa.